Nisa Investment Advisors’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-361
Closed -$1.78K 3094
2025
Q1
$1.78K Buy
361
+291
+416% +$925 ﹤0.01% 2497
2024
Q4
$206 Sell
70
-13,535
-99% -$55.5K ﹤0.01% 2930
2024
Q3
$64.2K Buy
13,605
+44
+0.3% +$198 ﹤0.01% 1575
2024
Q2
$52.2K Buy
+13,561
New +$61.1K ﹤0.01% 1655
2023
Q3
Sell
-43
Closed -$435 2836
2023
Q2
$435 Buy
43
+3
+8% +$32 ﹤0.01% 2589
2023
Q1
$0 Sell
40
-1,460
-97% -$16.7K ﹤0.01% 2713
2022
Q4
$14K Sell
1,500
-47
-3% -$663 ﹤0.01% 2135
2022
Q3
$25K Buy
1,547
+47
+3% +$698 ﹤0.01% 1994
2022
Q2
$20K Sell
1,500
-12,700
-89% -$173K ﹤0.01% 2050
2022
Q1
$242K Buy
14,200
+13,864
+4,126% +$235K ﹤0.01% 1305
2021
Q4
$6K Buy
+336
New +$10.5K ﹤0.01% 2082

Other funds holding TSVT

Nisa Investment Advisors's TSVT Position: Q2 2025 in Review

Nisa Investment Advisors sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 361 shares — an estimated $1.78K sold.

Nisa Investment Advisors first reported a position in TSVT in Q4 2021 and held it in 11 quarters. The position peaked at $242K in Q1 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Nisa Investment Advisors reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 361 2seventy bio shares in Q2 2025, an estimated $1.78K.
  • Nisa Investment Advisors first reported a position in 2seventy bio in Q4 2021 and held it in 11 quarters.
  • Nisa Investment Advisors's 2seventy bio position peaked at $242K in Q1 2022.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Nisa Investment Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.